Related Articles by Review for PMID: 32491590

Year	Number of Results
2003	2
2005	5
2006	1
2007	1
2009	1
2010	1
2011	1
2012	1
2013	3
2014	2
2015	2
2016	1
2017	1
2018	2
2020	1
2024	1
2025	1

1

Junaid SZS, Patel P, Patel JB. Junaid SZS, et al. 2024 Feb 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Feb 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32491590 Free Books & Documents.

2

Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride.

Padhi D, Harris R. Padhi D, et al. Clin Pharmacokinet. 2009;48(5):303-11. doi: 10.2165/00003088-200948050-00002. Clin Pharmacokinet. 2009. PMID: 19566113 Review.

3

Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism.

Yousaf F, Charytan C. Yousaf F, et al. Ren Fail. 2014 Feb;36(1):131-8. doi: 10.3109/0886022X.2013.832319. Epub 2013 Sep 24. Ren Fail. 2014. PMID: 24060145 Free article. Review.

4

Calcimimetics versus parathyroidectomy: What is preferable?

Rroji M, Spasovski G. Rroji M, et al. Int Urol Nephrol. 2018 Jul;50(7):1271-1275. doi: 10.1007/s11255-018-1838-5. Epub 2018 Mar 12. Int Urol Nephrol. 2018. PMID: 29532306 Review.

5

Cinacalcet: AMG 073, Calcimimetics--Amgen/NPS Pharmaceuticals, KRN 1493, NPS 1493.

[No authors listed] [No authors listed] Drugs R D. 2003;4(6):349-51. doi: 10.2165/00126839-200304060-00003. Drugs R D. 2003. PMID: 14584963 Review.

6

Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy.

Friedl C, Zitt E. Friedl C, et al. Drug Des Devel Ther. 2018 Jun 1;12:1589-1598. doi: 10.2147/DDDT.S134103. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29910605 Free PMC article. Review.

7

[Calcimimetic drugs in stage 3-5 chronic kidney disease].

Grzegorzewska AE, Niepolski L. Grzegorzewska AE, et al. Pol Merkur Lekarski. 2012 Apr;32(190):260-2. Pol Merkur Lekarski. 2012. PMID: 22708286 Review. Polish.

8

Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.

Dong BJ. Dong BJ. Clin Ther. 2005 Nov;27(11):1725-51. doi: 10.1016/j.clinthera.2005.11.015. Clin Ther. 2005. PMID: 16368445 Review.

9

Cinacalcet hydrochloride for the treatment of hyperparathyroidism.

Verheyen N, Pilz S, Eller K, Kienreich K, Fahrleitner-Pammer A, Pieske B, Ritz E, Tomaschitz A. Verheyen N, et al. Expert Opin Pharmacother. 2013 Apr;14(6):793-806. doi: 10.1517/14656566.2013.777041. Epub 2013 Mar 4. Expert Opin Pharmacother. 2013. PMID: 23452174 Review.

10

Etelcalcetide for the treatment of secondary hyperparathyroidism.

Hamano N, Komaba H, Fukagawa M. Hamano N, et al. Expert Opin Pharmacother. 2017 Apr;18(5):529-534. doi: 10.1080/14656566.2017.1303482. Epub 2017 Mar 15. Expert Opin Pharmacother. 2017. PMID: 28277829 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 32491590

23 results

Results by year